Participate in MDMA Studies

We are currently recruiting for the Phase 3 study of MDMA-assisted therapy for PTSD. Here is a list of all MAPS-sponsored trials on clinicaltrials.gov.

Learn about the MDMA Therapy Training Program

Training applications are open for clinicians and counselors who want to learn the modality of MDMA-Assisted Therapy

Read our Publications

MAPS PBC publishes research papers detailing the results of our clinical trials.

MAPS PBC in the Media

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

May 09, 2021

A Psychedelic Drug Passes Big Test for PTSD Treatment

May 03, 2021

New PTSD Treatments Emerge as Cases Rise Among Some Groups

Sept. 21, 2020

PTSD and psychoactive drugs: MDMA treatment shows potential, but others lack evidence

Sept. 21, 2020

The case for funding psychedelics to treat mental health

Oct 9, 2020

Announcements

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Careers
News
FAQ
Contact Us

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

Therapy Training

Overview
Application

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.